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Abstract. 
 
Survivin, a dimeric baculovirus inhibitor of
apoptosis repeat (BIR) motif protein that is principally
expressed in G2 and mitosis, has been associated with
protection against apoptosis of cells that exit mitosis ab-
errantly. Mammalian survivin has been reported to as-
sociate with centrosomes and with the mitotic spindle.
We have expressed a human hemagglutinin-tagged sur-
vivin plasmid to determine its localization, and ﬁnd in-
stead that it clearly acts as a passenger protein. In HeLa
 
cells, survivin ﬁrst associates with the kinetochores,
and then translocates to the spindle midzone during
anaphase and, ﬁnally, to the midbody during cell cleav-
age. Its localization is similar to that of TD-60, a known
passenger protein. Both a point mutation in the bacu-
lovirus IAP repeat motif (C84A) and a COOH-termi-
 
nal deletion mutant (
 
D
 
106) of survivin fail to localize to
either kinetochores or midbodies, but neither interferes
 
with cell cleavage. The interphase localization of sur-
vivin is cell cycle regulated since in permanently
transfected NIH3T3 cells it is excluded from the nu-
clei until G2, where it localizes with centromeres.
Survivin remains associated with mitotic kinetochores
when microtubule assembly is disrupted and its local-
ization is thus independent of microtubules. We con-
clude that human survivin is positioned to have an im-
portant function in the mechanism of cell cleavage.
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Introduction
 
Survivin, a baculovirus inhibitor of apoptosis (IAP)
 
1
 
 re-
peat (BIR) motif protein (Ambrosini et al., 1997), has
widespread tissue distribution and is expressed in many
solid tumors (Ambrosini et al., 1997; Lu et al., 1998). In-
creased levels of survivin expression correlate strongly
with cell survival after mitotic arrest by taxol, an inhibitor
of spindle function (Li et al., 1998), while repression of ex-
pression by an antisense leads to induction of apoptosis
(Ambrosini et al., 1998; Li et al., 1998). Survivin has been
also reported to associate with the centrosome (Li et al.,
1999), mitotic spindle, and midbody (Li et al., 1998). Based
on these features, survivin is thought to be a key player in
the pathway that links failure of mitotic checkpoint con-
trols to apoptotic activation.
Because of its BIR motif, survivin is a potential member
of the IAP family of proteins, which act at discrete steps to
regulate the apoptotic pathway of cell death (Deveraux
and Reed, 1999). The BIR motifs are essential for interac-
tion of the IAP proteins with proapoptotic proteins, in-
cluding the caspase family of death proteases. Not all BIR
motif proteins act as inhibitors of apoptosis, indicating that
they also have other functions. For example, the BIR motif
proteins most closely related to survivin, Bir1p in budding
yeast (Yoon and Carbon, 1999; Li et al., 2000), bir1 in fis-
sion yeast (Uren et al., 1999), and BIR-1 in 
 
Caenorhabditis
elegans 
 
(Fraser et al., 1999) are not involved in suppression
of apoptosis, but are implicated in spindle function and cell
cleavage. Further, recent evidence supports a role in mito-
sis for mammalian survivin, as its suppression by antisense
RNA expression generates failure in cell cleavage (Chen et
al., 2000) and leads to a multinucleate polyploid phenotype
(Li et al., 1999).
 
In 
 
C. elegans
 
, the survivin ortholog BIR-1 acts as a pas-
senger protein, first localizing to the chromosomes, and
then migrating to the midbody during cleavage (Speliotes
et al., 2000). Proteins of this class may play a role in induc-
tion of cleavage that coordinates with the position of the
spindle midzone (Earnshaw and Bernat, 1991; Martineau
et al., 1995).
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In contrast to expectation from the above analyses, im-
munofluorescence microscopy suggested that survivin as-
sociates with the mitotic spindle (Li et al., 1998) and with
the centrosomes in mammalian cells (Li et al., 1999). We
have addressed the localization of survivin in mammalian
cells by transfection of human hemagglutinin (HA)-tagged
survivin and have obtained clear evidence that survivin lo-
calizes strongly to kinetochores until metaphase, migrating
to the spindle midzone in early anaphase and to the cleav-
age furrow during telophase and cytokinesis. We find no
evidence that survivin directly associates with either mi-
crotubules or with centrosomes. Its mitotic behavior
closely duplicates that of TD-60, a known passenger pro-
tein (Andreassen et al., 1991).
We have also analyzed the localization of two HA-
tagged survivin mutants. The first mutant substitutes Ala
for a key cysteine (C84), disrupting the zinc finger in the
BIR motif (Chantalat et al., 2000). This mutant has been
reported to act as a dominant negative for apoptotic re-
sponse in mammalian cells (Li et al., 1998). The second
mutant is a truncation of the COOH-terminal 
 
a
 
-helical ex-
tensions of survivin. We find that both mutants fail to lo-
calize to either kinetochores or to the spindle midzone, but
do not interfere with cleavage. We conclude that survivin
is a genuine passenger protein and that the majority of its
structure is involved in its capacity for kinetochore and
spindle midzone localization.
 
Materials and Methods
 
Cloning and Mutagenesis
 
The full-length cDNA coding human survivin (Chantalat et al., 2000) was
introduced into the EcoRI site and in frame with the HA epitope in the
mammalian expression vector pJF-HA (Rousseau et al., 1999). The full-
length HA-chimeric survivin cDNA was subcloned into the XhoI-BamHI
sites of the pCDNA3.1(
 
2
 
) expression vector (Invitrogen).
The C84A mutant was obtained by site-directed mutagenesis using the
Quick Change Site-directed Mutagenesis kit (Stratagene). The oligonucle-
otide primer 5
 
9 
 
ATTCGTCCGGCGCCGCTTTCCTTTCTG 3
 
9
 
 and its
complementary were designed to substitute the Cys 84 to an Ala along
with a silent mutation generating a NarI restriction site. The EcoRI frag-
ment containing the mutant survivin was subcloned in pJF-HA vector.
The 
 
D
 
106 mutant was obtained by PCR introducing a stop codon (UAG)
in amino acid 107, using the construct pJF-HA-survivin as template. An
oligonucleotide 5
 
9
 
 CCGGAATTCTATCTGTCCAGTTTCAAAAATTC
3
 
9
 
 annealing at position 299–318 of survivin coding region and an oligonu-
cleotide 5
 
9
 
 TTTACTTCTAGGCCTGTA 3
 
9
 
 within the pJF-HA vector
were used for the amplification. 19 cycles of amplification were performed
using the Vent DNA Polymerase (Biolabs). The amplified fragment was
gel purified, subcloned in the EcoRI site of the pJF-HA vector, and its ori-
entation was confirmed by PCR. All constructs expressing survivin and its
mutants were confirmed by sequencing (Genome Express; Grenoble).
 
Cell Culture and Transfection
 
HeLa and NIH3T3 cells were grown as monolayers in Dulbecco’s Modi-
fied Eagle’s Medium (GIBCO BRL) supplemented with 10% fetal bovine
serum (Hyclone) and 10% bovine calf serum (Biological Industries), re-
spectively, and maintained in a humid incubator at 37
 
8
 
C in a 5% CO
 
2
 
 en-
vironment. Nocodazole, Taxol, and VP16 (Sigma-Aldrich) were dissolved
in DMSO.
HeLa cells (3 
 
3
 
 10
 
6
 
) were transfected by electroporation with 20 
 
m
 
g/ml
JF-HA-survivin plasmid with an EMC600 apparatus (BTX) according to
the manufacturer’s instructions and replated onto 10-mm dishes. Cells ad-
hered to coverslips in 35-mm dishes were also transfected by Exgen (Eu-
romedex) with 3 
 
m
 
g of JF-HA-survivin or JF-HA-C84A or JF-HA-
 
D
 
106
plasmids according to the manufacturer’s instructions. NIH3T3 cells trans-
fected with the pCDNA 3.1(
 
2
 
) carrying the HA-survivin were selected in
1.2 mg/ml geneticin G418 (GIBCO BRL).
 
Immunofluorescence Microscopy
 
Cells, grown on poly-
 
D
 
-lysine–coated glass coverslips for immunofluores-
cence microscopy, were fixed with 2% paraformaldehyde-PBS for 20 min
at 37
 
8
 
C, washed 5 min with PBS, permeabilized with 0.2% Triton X-100 in
PBS for 3 min, and washed three times for 5 min with PBS. Cells were
then processed with primary and secondary antibodies and counterstained
with propidium iodide, as described previously
 
 
 
(Martineau-Thuillier et al.,
1998). HA monoclonal antiserum (BabCo) was diluted 1,500-fold.
CREST GD and JH human autoimmune sera used to detect centromere
antigens and TD-60 (Andreassen et al., 1991), respectively, were diluted
500
 
3
 
. Secondary antibodies, including FITC-conjugated affinity purified
goat anti–mouse IgG (Jackson ImmunoResearch Laboratories), and
rhodamine-conjugated anti–human IgG, were used at 2.5 
 
m
 
g/ml. Images
were collected with a MRC-600 Laser Scanning Confocal Apparatus (Bio-
Rad Laboratories) coupled to a Nikon Optiphot microscope.
 
Cell Extracts and Immunoblotting
 
For the preparation of extracts, cells were centrifuged, washed with PBS
at 4
 
8
 
C, and lysed in 50 mM Tris-HCl, pH 7.5, 250 mM NaCl, 0.1% NP-40,
and 5 mM EGTA containing 50 mM NaF, 60 mM 
 
b
 
-glycerolphosphate,
0.5 mM Na-vanadate, 0.1 mM PMSF, 10 
 
m
 
g/ml aprotinin, and 10 
 
m
 
g/ml
leupeptin. Lysate supernatants were then collected by centrifugation at
13,000 
 
g
 
. For each sample, 10 
 
m
 
g of cell extracts were resolved on 15%
polyacrylamide gels using a mini-gel apparatus (Bio-Rad Laboratories)
and transferred to nitrocellulose. A monoclonal antiserum to HA, diluted
1,000-fold, and a peptide antibody recognizing the COOH terminus
(amino acids 110–123) of human survivin (Alpha Diagnostics Interna-
tional), diluted 2,000-fold, were used to detect expressed and endogenous
protein. Blots were exposed to HRP-conjugated goat anti–mouse antibod-
ies (KPL) and goat anti–rabbit IgG secondary diluted 5,000-fold (TAGO)
for 1 h, and then developed by enhanced chemiluminescence (Pierce
Chemical Co.).
 
Results
 
Transiently Expressed HA-Survivin Localizes as a 
Kinetochore Passenger Protein
 
We have transiently transfected HeLa cells with plasmid ex-
pressing human HA-tagged survivin by either electropora-
tion or with exgen, and have examined the protein’s local-
ization through the cell cycle. With either method the
results are equivalent. The HA antibody recognized one
strong band in Western blots of whole cell extracts, and re-
acted with no protein in control cells (Fig. 1 A). Western
blots with a survivin antibody confirmed the expression of
HA-tagged survivin at levels higher than the endogenous
protein (Fig. 1 A). The HA tag has been introduced into the
NH
 
2
 
 terminus of the protein, where structural analysis had
previously shown modification did not interfere with native
folding of the protein dimer (Chantalat et al., 2000).
The majority of interphase cells showed a disperse, but
particulate, distribution of survivin in the cytosol, and in
these cells survivin was specifically excluded from the nu-
cleus (Fig. 1 B, a). By contrast, some interphase cells had
nuclear staining with local punctate accumulations (Fig. 1
B, b). On entry into prophase, localization was entirely
punctate. As cells proceeded to metaphase, localization
was apparently associated with the centromeric elements
of the chromatin (Fig. 1 B, c–e).
During anaphase and telophase, survivin disassociated
from the chromatin and concentrated at the spindle equa-
tor as the chromosomes separated (Fig. 1 B, f–i), appar-
ently participating as an element of the telophase disc, a
structure that forms in late anaphase and contacts the cell
cortex at the position of the cleavage furrow (Cooke et al.,
1987; Martineau et al., 1995). 
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The association of survivin with the kinetochores in mi-
tosis was confirmed (Fig. 1 C) by counterstaining with a
CREST scleroderma autoimmune serum, which specifi-
cally reacts with centromere proteins and marks mitotic
kinetochores. Survivin staining overlapped (Fig. 1 C, yel-
low) with the centromere staining up to metaphase (Fig. 1
C, a and b). Entry into anaphase led to a redistribution of
survivin to the spindle midzone (Fig. 1 C, c and d) and
later to the midbody (e).
Comparison of the distribution of survivin with that of
TD-60, a passenger protein that we have previously de-
scribed (Andreassen et al., 1991), showed that the overlap
of stain (Fig. 1 C, yellow) between the two antigens was es-
sentially complete throughout mitosis (Fig. 1 D). There-
fore, survivin behaves as a passenger protein whose local-
ization changes dynamically with progression of mitosis.
 
Distribution of Survivin in a Permanently Expressing 
Clonal NIH3T3 Cell Line
 
We established an NIH3T3 cell line that permanently ex-
pressed human HA-tagged survivin, and found that the
distribution of survivin in this cell line was essentially iden-
tical to that described above for the transiently transfected
Figure 1. Transient overexpres-
sion of human survivin reveals
kinetochore and cleavage furrow
association. (A) Immunoblot
analysis of HeLa cell extracts us-
ing antibodies specific to HA
and to survivin from cells tran-
siently expressing HA-tagged
survivin. (B) Immunofluores-
cence microscopy of transfected
cells stained with anti–HA
(green) and propidium iodide
(red) for chromatin. In different
interphase cells, survivin local-
izes predominantly either in the
cytoplasm (a) or the nucleus (b).
In prophase through metaphase
(c–e), survivin localizes in dis-
tinct spots on the chromatin. In
anaphase, leaves the chromatin,
associates with the spindle mid-
zone (f), extending to the cortex
(g), and remains localized in telo-
phase (h) and the midbody (i).
(C) Survivin (green) colocalizes
with kinetochores stained with a
human CREST serum (red) dur-
ing mitosis until metaphase (a
and b), and then dissociates
from kinetochores and accumu-
lates in the cleavage furrow and
midbody (c–e). (D) Survivin
(green) colocalizes with the ki-
netochore passenger protein
TD-60 stained with a human au-
toimmune serum (red) through
all the stages of mitosis: (a)
prometaphase, (b) metaphase,
(c) anaphase, (d) telophase, and
(e) late telophase. Bar: 10 mm. 
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HeLa cells. In long term culture, we found no sign that
overexpression of HA-survivin influenced cell cycle distri-
bution or ploidy, as determined by FACscan
 
®
 
 analysis, nor
cell viability (data not shown) as previously reported for
murine survivin (TIAP) (Kobayashi et al., 1999).
 
As in HeLa, mitotic NIH3T3 cells showed that survivin
followed the typical distribution pattern of a passenger
protein (Fig. 2 A, a–f). The association of survivin with ki-
netochores did not depend on microtubules since it was re-
tained in the presence of the nocodazole and taxol, inhibi-
tors of microtubule dynamics (Fig. 2 B, a and b).
We note that transient and constitutive overexpression
of survivin in HeLa and NIH3T3 cells, respectively,
showed no evidence of association with the metaphase mi-
totic spindle, nor with the centrosomes, in contrast to pre-
vious reports (Li et al., 1998, 1999). The midbody stain is
the only previously reported localization consistent with
our results and with those in 
 
C. elegans
 
 (Speliotes et al.,
2000). Using a COOH-terminal–specific commercially
available antibody to survivin, we were unable to localize
survivin to any structure in the cell. Further, on repeated
attempts to demonstrate survivin binding to microtubules
in vitro, we found no evidence for specific association
(data not shown).
The ectopically expressed survivin is present throughout
the cell cycle, whereas the endogenous protein is ex-
pressed exclusively during G2/M (Li et al., 1998). How-
ever, the intracellular distribution of the constitutively ex-
pressed survivin appeared to be cell-cycle regulated. Most
randomly cycling interphase cells showed survivin ex-
cluded from the nuclei (Fig. 2 C, a). Recently divided cells
identified by midbodies were always negative for nuclear
stain (Fig. 2 C, a, arrowhead). A minority of cells showed
nuclear stain and this was strongly localized to cen-
tromeres (Fig. 2 C, a, arrow). By contrast, upon arrest in
G2 by VP16, an inhibitor of topoisomerase II, 90% of the
cells showed a nuclear punctate survivin distribution (Fig.
2, C, b, and B, c).
The data shown above suggest that entry of survivin into
the nucleus is cell-cycle regulated, and there might be a
mechanism of excluding survivin from the nucleus through
most of interphase. A mechanism for nuclear exclusion has
been elucidated for cyclin B, whose localization is con-
trolled by a nuclear export signal (NES) (Yang et al., 1998).
If a similar control regulates survivin nuclear export, the
NES must be present in an associated protein, as survivin
has no apparent NES. The control of survivin localization
and its function in interphase remain to be determined.
 
Both the BIR Motif and the COOH-Terminal Alpha 
Helical Extensions of Survivin Are Important to Its 
Mitotic Localization
 
Structural analysis shows survivin is a bow-tie–shaped
dimeric protein, with an NH
 
2
 
-terminal BIR motif and a
COOH-terminal 
 
a
 
-helical extension from each monomer
(Chantalat et al., 2000). The BIR motif contains a zinc finger
stabilized by residues C57, C60, H77, and C84. C84 is pre-
dicted to be essential to maintenance of the BIR motif. Fig.
3 A (red arrow) shows the structural position of this residue.
An earlier report gave evidence that mutation of cysteine 84
to alanine created a dominant-negative phenotype with re-
spect to suppression of apoptosis (Li et al., 1998). Further-
more, the survivin dimer has two unusual COOH-terminal
 
a
 
-helical extensions that appear to have an adaptor or dock-
ing function. We have also expressed a mutant form of sur-
vivin in which the COOH-terminal extensions were trun-
cated at residue 106 (Fig. 3 A, black arrow).
Figure 2. Cell-cycle distribution of survivin in permanently over-
expressing HA-tagged survivin NIH3T3 cells. Immunofluores-
cence microscopy of expressing cells stained with an anti–HA
(green) and propidium iodide (red). (A) During mitosis, survivin
localizes to kinetochores in late G2/prophase (a), prometaphase
(b), and metaphase (c). In late mitosis, survivin localizes to the
spindle midzone (d), and then the cleavage furrow (e) and mid-
body (f). (B) Survivin retains kinetochore localization after disrup-
tion of the mitotic spindle by nocodazole (0.1 mg/ml, a) or taxol (20
mM, b). (C) Low-magnification fields of random cycling cells and
cells blocked for 16 h in G2 with the topoisomerase II inhibitor
VP16 (2 mg/ml). In untreated cells, survivin exhibits a cytoplasmic
staining, nuclear punctate staining (arrow) and midbody staining
(arrowhead). In 90% of G2 arrested cells, (VP16) survivin has a
nuclear punctate distribution (right; see also B, c). Bar: 10 mm. 
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We transfected HeLa cells with C84A and 
 
D
 
106 mutants
of HA-tagged survivin, and observed that both mutants
(Fig. 3 B, green) distributed uniformly throughout the cy-
toplasm and did not localize to either kinetochores at
metaphase, nor the spindle midzone or midbody in telo-
phase, in contrast to the discrete localization observed
with wild-type transfection done under the same condi-
tions (Fig. 3 B). We conclude that both the COOH-termi-
nal extension and intact BIR motif are important to sur-
vivin localization.
It is worth noting that the C84A survivin remained
dimeric, as revealed by FPLC chromatography, despite ex-
tensive structural disruption (data not shown). The failure
of C84A and 
 
D
 
106 survivin to distribute as a passenger
protein did not give a dominant-negative phenotype. After
48 h of expression, cells carrying wild-type and C84A or
 
D
 
106 mutants showed 
 
z
 
2% binucleate and no micronucle-
ated cells. These results are compatible with the com-
pleted cleavage that we routinely saw in expressing cells
(Fig. 3 B, right).
Since C84A and 
 
D
 
106 mutants of survivin do not local-
ize to the kinetochore and cleavage furrow, we asked
whether overexpression of the two mutants altered TD-60
distribution during mitosis. Neither survivin mutant inter-
fered with the normal distribution of TD-60 to the kineto-
chores or to the telophase disc (Fig. 4, A–C).
As survivin and BIR1 depletion cause gross defects in
cleavage (Chen et al., 2000; Speliotes et al., 2000), we as-
sume that the native survivin in the transfected cells was
functioning normally and that the mutants we expressed
did not have a dominant-negative effect. Therefore, bind-
ing partners that may require survivin to function at the ki-
netochore and spindle midzone are probably in large ex-
cess over survivin, and insensitive to the presence of
nonfunctional protein.
 
Conclusions
 
Our results show that, during mitosis, human survivin lo-
calizes to the kinetochores until metaphase, and then re-
distributes to the spindle midzone and to the telophase
Figure 3. A BIR-motif C84A
mutation and a D106 COOH-
terminal truncation on survivin
abolish kinetochore and cleav-
age furrow association. (A)
Schematic representation of sur-
vivin and the introduced C84A
point mutation (red arrowhead)
and D106 deletion (black arrow-
head). The locations of the in-
troduced mutations are also de-
picted on the survivin dimer
crystal structure (Chantalat et
al., 2000). (B) Immunofluores-
cence microscopy of HeLa cells
transiently overexpressing wild-
type (WT) HA-survivin, HA-
C84A, and HA-D106 survivin
48 h after transfection. Cells
stained with anti–HA (green)
and propidium iodide (red). As
opposed to wild-type survivin,
neither mutant protein localizes
to kinetochores (left), the cleav-
age furrow (middle), or mid-
body (right). Bar: 10 mm. 
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disc during anaphase, ending in the midbody during cell
cleavage. The survivin localization to kinetochores is inde-
pendent of microtubules. On the basis of its localization,
survivin can be considered as one of the kinetochore pas-
senger proteins that extend to the cell cortex, sharing this
property with TD-60, INCENPs, and AIM-1 (Martineau-
Thuillier et al., 1998). This class of proteins has been previ-
ously shown to play a key role in the proper completion of
cytokinesis in mammalian cells (Martineau et al., 1995;
Mackay et al., 1998; Terada et al., 1998), and they may be
targeted as complexes to the central spindle and cleavage
furrow (Adams et al., 2000).
In contrast to the results in 
 
C. elegans
 
 (Speliotes et al.,
2000), we find human survivin specifically localizes to
early mitotic kinetochores rather than whole chromo-
somes. This discrepancy probably results from the holo-
centric nature of the nematode chromosomes during mito-
sis (Albertson and Thomson, 1982). In 
 
C. elegans
 
, BIR-1 is
also required for the localization of the aurora-like kinase
AIR-2 at the metaphase chromosome (Speliotes et al.,
Figure 4. The BIR-motif C84A
mutation and the D106 COOH-
terminal truncation on survivin
do not alter the distribution of
the kinetochore passenger pro-
tein TD-60. Double immunoflu-
orescence of HeLa cells tran-
siently transfected with wild
type (A), C84A (B), and D106
(C) survivin stained with anti–
HA (SRV) and with a human
autoimmune serum recognizing
TD-60. Both mutants of survivin
do not alter the TD-60 localiza-
tion to kinetochores (left) and
neither mutant alters the distri-
bution of TD-60 to the cleavage
furrow (middle) or to midbody
(left). Bar: 10 mm. 
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2000). AIR-2 also appears to be a passenger protein, and
lack of either AIR-2 or BIR-1 causes failure of cell cleav-
age. Furthermore, the observed kinetochore association of
survivin is in agreement with data in budding yeast, where
Bir1p, through its COOH terminus, associates with mem-
bers of the CBF3 centromeric protein complex (Yoon and
Carbon, 1999).
In addition, we show that neither a COOH-terminal
truncation mutant nor a BIR motif point mutant of sur-
vivin could localize to kinetochores or the spindle midzone
in mitosis, but were instead dispersed throughout the cell.
These results suggest that the BIR domain and the
COOH-terminal 
 
a
 
-helices both contribute to the proper
dynamic redistribution of survivin during mitosis. How-
ever, neither mutant interferes with any aspect of chromo-
some separation or cell cleavage, at least at the expression
levels attained.
Survivin, like other BIR motif proteins, has the poten-
tial to inhibit apoptosis by directly suppressing the activity
of caspases; however, suppression of caspase activity by
survivin is controversial (Verdecia et al., 2000). The sur-
vivin orthologs in lower eukaryotes appear to have no
function in protection from cell death, but instead are di-
rectly involved in chromosome segregation, spindle elon-
gation, and cell cleavage events (Fraser et al., 1999; Uren
et al., 1999; Yoon and Carbon, 1999; Speliotes et al., 2000).
It remains possible that human survivin has acquired IAP
functions that its orthologs in lower eukaryotes do not
have, and thus has roles to play in both the completion of
late mitosis and in the inhibition of apoptosis.
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